Gyon Technologies Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-38,872
| Closed | -$2.17M | – | 543 |
|
|
2022
Q2 | $2.17M | Buy |
+38,872
| New | +$2.17M | 0.61% | 46 |
|
|
2022
Q1 | – | Sell |
-12,402
| Closed | -$695K | – | 471 |
|
|
2021
Q4 | $695K | Sell |
12,402
-718
| -5% | -$40.2K | 0.13% | 221 |
|
|
2021
Q3 | $630K | Sell |
13,120
-1,580
| -11% | -$75.9K | 0.17% | 178 |
|
|
2021
Q2 | $616K | Buy |
14,700
+5,400
| +58% | +$226K | 0.2% | 157 |
|
|
2021
Q1 | $314K | Buy |
+9,300
| New | +$314K | 0.14% | 261 |
|
|
2020
Q4 | – | Sell |
-15,028
| Closed | -$522K | – | 414 |
|
|
2020
Q3 | $522K | Buy |
+15,028
| New | +$522K | 0.41% | 94 |
|
|
2020
Q2 | – | Sell |
-48,956
| Closed | -$1.47M | – | 128 |
|
|
2020
Q1 | $1.47M | Buy |
+48,956
| New | +$1.47M | 2.83% | 5 |
|